Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients

NCT01341808 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

493

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Disease
Crohn's Disease
Ulcerative Colitis
Hepatitis A

Interventions

BIOLOGICAL: Epaxal Berna (virosomal hepatitis A vaccine)

Sponsor

Asan Medical Center